These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Bioconjugated gold nanoparticles enhance cellular uptake: A proof of concept study for siRNA delivery in prostate cancer cells. Guo J, O'Driscoll CM, Holmes JD, Rahme K. Int J Pharm; 2016 Jul 25; 509(1-2):16-27. PubMed ID: 27188645 [Abstract] [Full Text] [Related]
3. Novel epithelial cell adhesion molecule antibody conjugated polyethyleneimine-capped gold nanoparticles for enhanced and targeted small interfering RNA delivery to retinoblastoma cells. Mitra M, Kandalam M, Rangasamy J, Shankar B, Maheswari UK, Swaminathan S, Krishnakumar S. Mol Vis; 2013 Jul 25; 19():1029-38. PubMed ID: 23687439 [Abstract] [Full Text] [Related]
4. Anisamide-targeted PEGylated gold nanoparticles designed to target prostate cancer mediate: Enhanced systemic exposure of siRNA, tumour growth suppression and a synergistic therapeutic response in combination with paclitaxel in mice. Luan X, Rahme K, Cong Z, Wang L, Zou Y, He Y, Yang H, Holmes JD, O'Driscoll CM, Guo J. Eur J Pharm Biopharm; 2019 Apr 25; 137():56-67. PubMed ID: 30779980 [Abstract] [Full Text] [Related]
6. Gold nanoparticles capped with polyethyleneimine for enhanced siRNA delivery. Song WJ, Du JZ, Sun TM, Zhang PZ, Wang J. Small; 2010 Jan 25; 6(2):239-46. PubMed ID: 19924738 [Abstract] [Full Text] [Related]
7. Amphiphilic gold nanoparticles displaying flexible bifurcated ligands as a carrier for siRNA delivery into the cell cytosol. Niikura K, Kobayashi K, Takeuchi C, Fujitani N, Takahara S, Ninomiya T, Hagiwara K, Mitomo H, Ito Y, Osada Y, Ijiro K. ACS Appl Mater Interfaces; 2014 Dec 24; 6(24):22146-54. PubMed ID: 25466488 [Abstract] [Full Text] [Related]
11. Efficacious cellular codelivery of doxorubicin and EGFP siRNA mediated by the composition of PLGA and PEI protected gold nanoparticles. Kumar K, Vulugundam G, Jaiswal PK, Shyamlal BRK, Chaudhary S. Bioorg Med Chem Lett; 2017 Sep 15; 27(18):4288-4293. PubMed ID: 28838699 [Abstract] [Full Text] [Related]
12. Folate-targeted amphiphilic cyclodextrin.siRNA nanoparticles for prostate cancer therapy exhibit PSMA mediated uptake, therapeutic gene silencing in vitro and prolonged circulation in vivo. Evans JC, Malhotra M, Guo J, O'Shea JP, Hanrahan K, O'Neill A, Landry WD, Griffin BT, Darcy R, Watson RW, O'Driscoll CM. Nanomedicine; 2016 Nov 15; 12(8):2341-2351. PubMed ID: 27389146 [Abstract] [Full Text] [Related]
13. Delivering siRNA to control osteogenic differentiation and real-time detection of cell differentiation in human mesenchymal stem cells using multifunctional gold nanoparticles. Wu Q, Wang K, Wang X, Liang G, Li J. J Mater Chem B; 2020 Apr 21; 8(15):3016-3027. PubMed ID: 32207489 [Abstract] [Full Text] [Related]
15. PEGylated polyethylenimine-entrapped gold nanoparticles modified with folic acid for targeted tumor CT imaging. Zhou B, Yang J, Peng C, Zhu J, Tang Y, Zhu X, Shen M, Zhang G, Shi X. Colloids Surf B Biointerfaces; 2016 Apr 01; 140():489-496. PubMed ID: 26812636 [Abstract] [Full Text] [Related]
16. Prostate cancer cell-specific VEGF siRNA delivery system using cell targeting peptide conjugated polyplexes. Kim SH, Lee SH, Tian H, Chen X, Park TG. J Drug Target; 2009 May 01; 17(4):311-7. PubMed ID: 19242850 [Abstract] [Full Text] [Related]
17. Folic acid-functionalized polyethylenimine superparamagnetic iron oxide nanoparticles as theranostic agents for magnetic resonance imaging and PD-L1 siRNA delivery for gastric cancer. Luo X, Peng X, Hou J, Wu S, Shen J, Wang L. Int J Nanomedicine; 2017 May 01; 12():5331-5343. PubMed ID: 28794626 [Abstract] [Full Text] [Related]